Thomas Jefferson University

Remote Electrical Neuromodulation FDA Clearance for Migrane Sufferers

Theranica announced that its Nerivio medical device has received Food and Drug Administration clearance for an expanded indication encompassing acute treatment of chronic migraine in people 18 years and older.

Using AI to predict risk of thyroid cancer on ultrasound

Thyroid nodules are small lumps that form within the thyroid gland and are quite common in the general population, with a prevalence as high as 67%. The great majority of thyroid nodules are not cancerous and cause no symptoms. However, there are currently limited guidelines on what to do with a nodule when the risk of cancer is uncertain.

Neuromodulation for migrane relief

electroCore, LLC has received clearance from the U.S. Food and Drug Administration for an expanded label for gammaCore as an acute treatment of pain associated with migraine in adult patients. gammaCore therapy is a proprietary, non-invasive neuromodulation treatment delivered by a hand-held unit that stimulates the vagus nerve through the skin.

Artificial intelligence may help diagnose tuberculosis in remote areas

Researchers are training artificial intelligence models to identify tuberculosis on chest X-rays, which may help screening and evaluation efforts in TB-prevalent areas with limited access to radiologists, according to a new study

First non-invasive vagus nerve stimulation therapy for acute pain

The U.S. Food and Drug Administration released the use of gammaCore® (non-invasive vagus nerve stimulator) for the acute treatment of pain associated with episodic cluster headache in adult patients.

UK - Smart bra to diagnose breast cancer may be available in 2 years

Women may soon be able to self diagnose breast cancer with the help of a smart bra which is being developed by researchers at the Centre for Materials Research and Innovation (CMRI) at the University of Bolton, UK.